Supplement to Gastroenterology 2008;134(4 suppl1):A629 (W1079) Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? Antonio Nouvenne1, Andrea Maini1, Lucas Giovanni Cavallaro6, Roberta Merli1, Loredana Guida1, Ester Morana1, Margherita Curlo1, Andrea Iori1, Laura Martelli3, Mario Martelli3, Giulia Martina Cavestro1, Iva Pelosini5, Carmelo Scarpignato4, Angelo Franzè2, Francesco Di Mario1 1. Department of Clinical Sciences, University of Parma, Parma, Italy, 2. Gastroenterology Unit, Hospital of Parma, Parma, Italy, 3. Department of Chemistry, University of Padua, Padua, Italy, 4. Department of Anatomy, Pharmacology and Forensic Sciences, School of Medicine and Dentistry-Laboratory of Clinical Pharmacology, University of Parma, Parma, Italy, 5. Institute of Pharmacology, School of Medicine & Dentistry, University of Parma, Parma, Italy, 6. Gastroenterology Unit, S.Martino Hospital, Belluno, Belluno, Italy INTRODUCTION: Functional dyspepsia is an very frequent disease. Up to now many treatments are been proposed with conflicting results. Curcumin, the main element of turmeric powder extract from Curcuma Longa, shows both antinflammatory and antioxidant properties. Infact it is an agonist of vanilloid receptor(TRPV1)which plays a critical role in thermal nociception and inflammatory hyperalgesia. Domperidon is a dopamine antagonist currently used for treatment of dyspepsia. AIMS: To evaluate if a two months therapy schedule based on Curcumin or Domperidon is effective on:1)symptoms relief.2) gastric inflammation assessed by means of serum pepsinogen II in functional dyspepsia. MATERIALS AND METHODS:48 consecutive H.pylori negative patients (17 M, mean age 47,7±13 years, range 20-72) with functional dyspepsia, according with Rome III Criteria, were enrolled from January to December 2006. Patients after informed consent were randomized in two groups to take t.i.d. for 2 months: a tablet, containing curcumin 30 mg, Zn++-acetate 15 mg, bovine lactoferrin 100 mg (LF-500, Dicofarm, Rome, Italy) (Group A, 27 pts)or Domperidon 10 mg (Group B, 21 pts). Upper GI symptoms were assessed and scored by administering a validated questionnaire (Veldhuyzen S. APT.2006;23:521-9) at baseline (T0) and after two months(T1). Gastro-oesophageal mucosal integrity and H.pylori status were assessed by upper endoscopy with histology (five biopsies histologically classified according with the Sydney System) and a blood sample for serum pepsinogens (sPGI,sPGII), gastrin-17(G- 17) and anti-Helicobacter IgG (IgG-Hp) (EIA,Biohit,Helsinki,Finland). RESULTS: There was a significant decrease in the global overall symptoms both in Group A and in Group B (Group A: T0: 17.6±4.6, T1: 10.77±3.44, p< 0.001; Group B: T0 17.19±4.49, T1 12.79±3.44 p<0.001). sPGII levels decreased in Group A in a statistically significant manner (T0: 14.7±5.7; T1: 10.13±2.15, p=0.003)but not in Group B. sPGI,IgG and G-17 values did not significantly decrease after two months. CONCLUSION: Curcumin as well Domperidon is effective on improving dyspeptic symptoms. Curcumin but not Domperidon seems to reduce gastric inflammation assessed by serological marker according with its properties in improving the TNF cascade events. Further studies are necessary to confirm this results.
Myocardial Perfusion patient information sheet You have been scheduled for a Myocardial Perfusion scan or Lexiscan Myocardial Perfusion scan. Please stop all food and drink (6) hours prior to your appointment time, with the exception of water. Sips of water may be taken with medication(s). NO COFFEE, DECAF COFFEE, TEA, DECAF TEA, HERBAL TEA, SODAS, DECAFFEINATED SODAS, CAFFEINATED BEVERA
STATE OF ALASKA Victim Sexual Assault Evidence Kit Medical History – Step 1B TO BE COMPLETED BY THE MEDICAL PROVIDER Time assessment started: _________________ pm Time assessment ended: ________________ MEDICAL HISTORY: If yes, list: ___________________________________________________________ If yes, list: _________________________________________________________________________